Kindstar Globalgene Technology Inc. held its annual general meeting on June 5, 2025. The proposal to receive the audited consolidated financial statements and the reports of the directors and auditors for the year ended December 31, 2024, was approved. The proposal to re-elect Dr. Huang Shiang as an executive Director of the Company was also approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.